Global disease burden of stroke attributable to high fasting plasma glucose in 204 countries and territories from 1990 to 2019: An analysis of the Global Burden of Disease Study

Abstract

Background High fasting plasma glucose (HFPG) is the leading risk factor contributing to the increase of stroke burden in the past three decades. However, the global distribution of stroke burden specifically attributable to HFPG was not studied in depth. Therefore, we analyzed the HFPG‐attributable burden in stroke and its subtypes in 204 countries and territories from 1990 to 2019. Methods Detailed data on stroke burden attributable to HFPG were obtained from the Global Burden of Disease Study 2019. The numbers and age‐standardized rates of stroke disability‐adjusted life years (DALYs), deaths, years lived with disability, and years of life lost between 1990 and 2019 were estimated by age, sex, and region. Results In 2019, the age‐standardized rate of DALYs (ASDR) of HFPG‐attributable stroke was 354.95 per 100 000 population, among which 49.0% was from ischemic stroke, 44.3% from intracerebral hemorrhage, and 6.6% from subarachnoid hemorrhage. The ASDRs of HFPG‐attributable stroke in lower sociodemographic index (SDI) regions surpassed those in higher SDI regions in the past three decades. Generally, the population aged over 50 years old accounted for 92% of stroke DALYs attributable to HFPG, and males are more susceptible to HFPG‐attributable stroke than females across their lifetime. Conclusions Successful key population initiatives targeting HFPG may mitigate the stroke disease burden. Given the soaring population‐attributable fractions of HFPG for stroke burden worldwide, each country should assess its disease burden and determine targeted prevention and control strategies.

Spirometric Assessment of Pulmonary Function Tests in Asthma Patients

“…In 2019, the global prevalence of asthma was estimated to be 11.5% in people aged five to 69 years [ 3 ]. According to the Global Burden of Disease 2019 estimates, the prevalence of asthma in India is estimated to be 34.3 million, which accounts for 13.09% of the global burden [ 4 ].…”

High-risk population and factors of stroke has changed among middle-aged and elderly Chinese—Evidence from 1989 to 2015

“…According to global burden of disease study (GBD) in 2019, stroke is the first cause of life expectancy loss in China (7). The incidence of stroke in China decreased from 222/100,000 in 2005 to 201/100,000 in 2019, and the incidence of ischemic stroke increased from 117/100,000 in 2005 to 145/100,000 in 2019 (8,9). China is the largest developing country with about one-fifth of the world's population and the highest number of stroke cases in the world.…”

M6A modification promotes blood-brain barrier breakdown during cerebral ischemia/reperfusion injury through increasing matrix metalloproteinase 3 expression

“…Ischemic stroke is still one of the major causes of disability and mortality worldwide, and causes serious sociodemographic and socioeconomic burden [ 1 ]. Although thrombolysis and thrombectomy are wildly used in clinical for patients with cerebral ischemia, the therapeutic effect is not very ideal, owing to the narrow therapeutic window and hemorrhagic transformation risk [ 2 , 3 ].…”